Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synvivia

Synvivia
2016 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$295K LATEST DEAL AMOUNT
2 INVESTORS
Description

Owner and operator of a biotechnology company intended to focus on developing engineered organisms that safely and effectively treat diseases. The company's genetically engineered organisms are controlled by small molecules over protein function and by generating biosensors that identify and improve new enzymatic activities, enabling healthcare providers to diagnose the disease easily and give proper treatment to the patients.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2341 Grant Street
  • Unit B
  • Berkeley, CA 94703
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Synvivia’s full profile, request a free trial.

Synvivia Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $295K 00000 Completed Startup
1. Accelerator/Incubator 01-Jan-2016 00000 00000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Synvivia Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0

Synvivia Executive Team (1)

Name Title Board
Seat
Contact
Info
Gabriel Lopez Ph.D Founder, President, Chief Executive Officer & Chief Financial Officer